Nasdaq:US$16.85 (+1.02) | HKEX:HK$25.45 (-0.30) | AIM:£2.60 (-0.07)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004

1 items
a090729